SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050867
Filing Date
2020-11-05
Accepted
2020-11-05 07:23:27
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20200930.htm 10-Q 2668427
2 EX-31.1 imra-ex311_8.htm EX-31.1 19385
3 EX-31.2 imra-ex312_6.htm EX-31.2 19623
4 EX-32.1 imra-ex321_9.htm EX-32.1 9851
5 EX-32.2 imra-ex322_10.htm EX-32.2 10054
  Complete submission text file 0001564590-20-050867.txt   7204697

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imra-20200930.xml EX-101.INS 1307896
7 XBRL TAXONOMY EXTENSION SCHEMA imra-20200930.xsd EX-101.SCH 44371
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20200930_cal.xml EX-101.CAL 38840
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20200930_def.xml EX-101.DEF 145783
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20200930_lab.xml EX-101.LAB 347945
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20200930_pre.xml EX-101.PRE 293151
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 201288672
SIC: 2834 Pharmaceutical Preparations